Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BioMed Realty Trust's Enterprise Value is $4,846.0 Mil.
BioMed Realty Trust's EBIT for the trailing twelve months (TTM) ended in Sep. 2015 was $302.8 Mil. Therefore, BioMed Realty Trust's EV-to-EBIT ratio for today is 16.00.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, BioMed Realty Trust's Enterprise Value is $4,846.0 Mil.
BioMed Realty Trust's EBITDA for the trailing twelve months (TTM) ended in Sep. 2015 was $560.9 Mil. Therefore, BioMed Realty Trust's EV-to-EBITDA ratio for today is 8.64.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, BioMed Realty Trust's Enterprise Value is $4,846.0 Mil.
BioMed Realty Trust's Revenue for the trailing twelve months (TTM) ended in Sep. 2015 was $676.0 Mil. Therefore, BioMed Realty Trust's EV-to-Revenue ratio for today is 7.17.
BioMed Realty Trust Enterprise Value Historical Data
The historical data trend for BioMed Realty Trust's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioMed Realty Trust's Enterprise Value
For the REIT - Office subindustry, BioMed Realty Trust's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioMed Realty Trust's Enterprise Value Distribution in the REITs Industry
For the REITs industry and Real Estate sector, BioMed Realty Trust's Enterprise Value distribution charts can be found below:
* The bar in red indicates where BioMed Realty Trust's Enterprise Value falls into.
BioMed Realty Trust Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
BioMed Realty Trust's Enterprise Value for the fiscal year that ended in Dec. 2014 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioMed Realty Trust (NYSE:BMR) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
BioMed Realty Trust's current Enterprise Value is $4,846.0 Mil.
BioMed Realty Trust's EBIT for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $302.8 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
BioMed Realty Trust's current Enterprise Value is $4,846.0 Mil.
BioMed Realty Trust's EBITDA for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $560.9 Mil.
BioMed Realty Trust's current Enterprise Value is $4,846.0 Mil.
BioMed Realty Trust's Revenue for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $676.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioMed Realty Trust Enterprise Value Related Terms
Thank you for viewing the detailed overview of BioMed Realty Trust's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
BioMed Realty Trust (BioMed Realty Trust) Business Description
BioMed Realty Trust Inc, a Maryland corporation was formed on April 30, 2004 and commenced operations on August 11, 2004, after completing its initial public offering. The Company operates as a self-administered and self-managed real estate investment trust focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry mainly through its subsidiary, BioMed Realty, L.P., a Maryland limited partnership Its tenants mainly include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are generally located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/ New Jersey. The Company faces competition from various entities for investment opportunities in properties for life science tenants, including other REITs, such as health care REITs and suburban office property REITs, pension funds, insurance companies, investment funds and companies, partnerships, and developers. The Company's properties are subject to various laws, ordinances and regulations, including regulations relating to common areas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BMR has been successfully added to your 